Higher quality of molecular testing, an unfulfilled priority: Results from external quality assessment for KRAS mutation testing in colorectal cancer.

@article{Tembuyser2014HigherQO,
  title={Higher quality of molecular testing, an unfulfilled priority: Results from external quality assessment for KRAS mutation testing in colorectal cancer.},
  author={Lien Tembuyser and Marjolijn J. L. Ligtenberg and Nicola Normanno and Sofie Delen and Johan Hjm van Krieken and Elisabeth M. C. Dequeker},
  journal={The Journal of molecular diagnostics : JMD},
  year={2014},
  volume={16 3},
  pages={371-7}
}
Precision medicine is now a key element in clinical oncology. RAS mutational status is a crucial predictor of responsiveness to anti-epidermal growth factor receptor agents in metastatic colorectal cancer. In an effort to guarantee high-quality testing services in molecular pathology, the European Society of Pathology has been organizing an annual KRAS external quality assessment program since 2009. In 2012, 10 formalin-fixed, paraffin-embedded samples, of which 8 from invasive metastatic… CONTINUE READING
Highly Cited
This paper has 25 citations. REVIEW CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…